C. Jason Mallo, DO. Division Medical Director, Maine Medical Center Department of Psychiatry, Adult Outpatient Psychiatry. Assistant Clinical Professor, Tufts University School of Medicine.
Dr. Mallo has no financial relationships with companies related to this material.
Mark L. Ruffalo, MSW, DPsa. Editor in Chief, The Carlat Psychotherapy Report, psychotherapist in private practice in Tampa, Florida, and Assistant Professor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine. He has broad clinical experience in the psychoanalytic treatment of mood, personality, and psychosomatic disorders, and has particular interest in the psychotherapy of schizophrenia and borderline personality disorder.
Dr. Ruffalo has no financial relationships with companies related to this material.
Frank Yeomans, MD, PhD. Adjunct Associate Clinical Professor of Psychiatry, Columbia University Vagelos College of Physicians and Surgeons. Psychiatrist in private practice.
Dr. Yeomans has no financial relationships with companies related to this material.
Mark L. Ruffalo, MSW, DPsa
Editor in Chief, The Carlat Psychotherapy Report. Psychotherapist in private practice in Tampa, Florida. Instructor of Psychiatry at the University of Central Florida College of Medicine and Adjunct Instructor of Psychiatry at Tufts University School of Medicine.
Dr. Ruffalo has no financial relationships with companies related to this material.
Susie Morris, MD, MA. Assistant professor of psychiatry and forensic psychiatrist, UCLA. Los Angeles, CA.
Dr. Morris has no financial relationships with companies related to this material.
Simon M. Dosovitz, MD. Dr. Dosovitz has no financial relationships with companies related to this material.
Ashley Pierson, PhD
Assistant Professor of Psychiatry and acting director of DBT services, General Adult Intensive Outpatient Program, Yale University, New Haven, CT.
Dr. Pierson, expert for this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.
_-The-Breakthrough-Antipsychotic-That-Could-Change-Everything.webp?1729528747 "KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg")
